#weight-loss-drugs

India's ₹750 Weight-Loss Shot: Semaglutide Goes Generic

Semaglutide's patent expired in India on March 20, and generics now undercut the originator by up to 80% — Sun Pharma's at about ₹750 a weekly shot. A public-health turning point, and its cautions.